Eledon Pharmaceuticals: At The Forefront Of The Organ Transplant Management Business

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN ) has been at the forefront of the revolutionary pig-to-human organ transplant story, having provided its lead immunosuppressive molecule Tegoprubart for both heart and kidney transplant experiments. It uses its immunology expertiseAbout the TPT serviceThanks for reading. At the Total Pharma Tracker, we offer the following:-Our Android app and website features a set of tools for DIY investors, including a work-in-progress software where you can enter any ticker and ...